XBiotech (XBIT) Debt Ratio (2024)
XBiotech's (XBIT) Debt Ratio stood at 0.05 in Q4 2024, up 8.0% from the prior quarter.
Powered by 
Analysis
XBiotech (XBIT) Debt Ratio (2024) Analysis & Trends
Starting with Q1 2024, XBiotech's Debt Ratio history includes 4 quarters.
- Per Business Quant, the preceding three quarters came in at 0.05 (Q3 2024), 0.05 (Q2 2024) and 0.04 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,158.59 Bn | 1,127.17 Bn | 19.71 Bn | 0.39 |
| 2 | Johnson & Johnson | 624.14 Bn | 542.67 Bn | 17.26 Bn | 0.24 |
| 3 | AbbVie | 510.94 Bn | 484.05 Bn | 12.70 Bn | 0.52 |
| 4 | Merck | 366.31 Bn | 320.69 Bn | 12.21 Bn | 0.42 |
| 5 | Novartis Ag | 295.90 Bn | 259.89 Bn | 11.24 Bn | 0.08 |
| 6 | Astrazeneca | 260.49 Bn | 234.18 Bn | 12.86 Bn | 0.28 |
| 7 | Amgen | 235.12 Bn | 190.52 Bn | 7.24 Bn | 0.60 |
| 8 | Gilead Sciences | 193.61 Bn | 167.81 Bn | 6.22 Bn | 0.53 |
| 9 | Pfizer | 171.37 Bn | 118.01 Bn | 10.94 Bn | 0.31 |
| 10 | XBiotech | 62.35 Mn | -473.07 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 0.05 |
| Mar 31, 2024 | 0.04 |
API Access
XBiotech Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();